Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bavarian Nordic
BAVACurrent price
169.1 DKK
-10.89 DKK (-6.06%)
Last closed
204.8 DKK
Company
www.bavarian-nordic.com
ISIN
DK0015998017
Sector
Healthcare
Industry
Biotechnology
Exchange
Copenhagen Exchange
Capitalization
16 570 044 926 DKK
Yield for 12 month
+18.75 %
1Y
3Y
5Y
10Y
15Y
BAVA
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase III clinical trial for the treatment of SARS-CoV-2. The company has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. It operates in the United States, Canada, France, Germany, Spain, Australia, Switzerland, Sweden, Chile, Taiwan, the United Kingdom, Hong Kong, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark. Address: Philip Heymans Alle 3, Hellerup, Denmark, 2900
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2 180.02 DKKP/E ratio
23.1521Dividend Yield
–Current Year
+7 142 340 676 DKK
Last Year
+3 186 484 506 DKK
Current Quarter
+1 443 667 377 DKK
Last Quarter
+840 890 734 DKK
Current Year
+4 655 188 320 DKK
Last Year
+1 720 533 532 DKK
Current Quarter
+728 105 437 DKK
Last Quarter
+268 239 524 DKK
Key Figures BAVA
1 year
3 years
5 years
10 years
EBITDA
1 977 592 874 DKK
Operating Margin TTM
PE Ratio
23.1521
Return On Assets TTM
5.99 %
PEG Ratio
–
Return On Equity TTM
7.03 %
Wall Street Target Price
2 180.02 DKK
Revenue TTM
6 151 531 839 DKK
Book Value
133.39 DKK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-28.1 %
Dividend Yield
–
Gross Profit TTM
1 720 533 531 DKK
Earnings per share
9.11 DKK
Diluted Eps TTM
9.11 DKK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-53.5 %
Profit Margin
11.63 %
Dividend Analytics BAVA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BAVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
694:549
Payout Ratio
–
Last Split Date
10.03.2020
Dividend Date
–
Stock Valuation BAVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
23.1521
Forward PE
4.99
Enterprise Value Revenue
2.3205
Price Sales TTM
2.6936
Enterprise Value EBITDA
9.9755
Price Book MRQ
1.5548
Financials BAVA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BAVA
For 52 weeks
139.66 DKK
303.4 DKK
50 Day MA
229.94 DKK
Shares Short Prior Month
–
200 Day MA
190.72 DKK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart